Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68.86 USD | +5.82% | +6.48% | +270.02% |
Apr. 25 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
Apr. 24 | Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 7.59B |
---|---|---|---|---|---|
Net income 2024 * | -117M | Net income 2025 * | -165M | EV / Sales 2024 * | - |
Net cash position 2024 * | 895M | Net cash position 2025 * | 749M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-63
x | P/E ratio 2025 * |
-45.2
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.96% |
Latest transcript on Viking Therapeutics, Inc.
1 day | +5.82% | ||
1 week | +6.48% | ||
Current month | -16.02% | ||
1 month | -0.48% | ||
3 months | +220.13% | ||
6 months | +545.36% | ||
Current year | +270.02% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Lian
FOU | Founder | 58 | 12-09-23 |
Gregory Zante
DFI | Director of Finance/CFO | 53 | 16-01-04 |
Marianne Mancini
COO | Chief Operating Officer | 59 | 15-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Foehr
BRD | Director/Board Member | 51 | 14-04-30 |
J. Singleton
BRD | Director/Board Member | 71 | 14-04-30 |
Charles Rowland
BRD | Director/Board Member | 65 | 17-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.13% | 2 M€ | -.--% | ||
0.06% | 7 M€ | -.--% | - | |
0.00% | 34 M€ | +2.22% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 68.86 | +5.82% | 3,526,931 |
24-04-24 | 65.07 | +0.22% | 2,584,595 |
24-04-23 | 64.93 | +1.69% | 2,032,588 |
24-04-22 | 63.85 | +0.68% | 1,562,386 |
24-04-19 | 63.42 | -1.93% | 3,060,725 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+270.02% | 7.59B | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.49% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- VKTX Stock